tradingkey.logo
tradingkey.logo
検索

IDEXX Laboratories Inc

IDXX
ウォッチリストに追加
570.210USD
+9.830+1.75%
終値 10-26 16:00(ET)
44.92B時価総額
41.67直近12ヶ月PER

IDEXX Laboratories Incについて 企業名

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc プロフィール

企業コードIDXX
会社名IDEXX Laboratories Inc
上場日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)
従業員数11000
証券種類Ordinary Share
決算期末Jun 21
本社所在地One Idexx Drive
都市WESTBROOK
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号04092-2041
電話番号12075560300
ウェブサイトhttps://www.idexx.com/
企業コードIDXX
上場日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)

IDEXX Laboratories Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
--
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
--
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
--
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
--
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%

よくある質問

IDEXX Laboratories Incの上位5名の株主は誰ですか?

IDEXX Laboratories Incの上位5名の株主は以下のとおりです。Mr. Michael G. (Mike) Erickson, Ph.D.

IDEXX Laboratories Inc(IDXX)の株式を保有している機関の数はいくつですか?

2026Q1時点で、IDEXX Laboratories Incの株式を保有している機関は2458社あり、保有株式の総市場価値は約76.16Mで、全体の96.54%を占めています。2025Q4と比較して、機関の持ち株は-2089033.00増加しています。

IDEXX Laboratories Incの最大の収益源は何ですか?

2026Q1において、CAG Diagnostics recurring revenue部門がIDEXX Laboratories Incにとって最大の収益を生み出しており、その金額は974.71Mで、全収益の80.12%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。